Prognostic gene signatures for non-small-cell lung cancer

Resectable non-small-cell lung cancer (NSCLC) patients have poor prognosis, with 30–50% relapsing within 5 years. Current staging criteria do not fully capture the complexity of this disease. Survival could be improved by identification of those early-stage patients who are most likely to benefit fr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Boutros, Paul C., Lau, Suzanne K., Pintilie, Melania, Liu, Ni, Shepherd, Frances A., Der, Sandy D., Tsao, Ming-Sound, Penn, Linda Z., Jurisica, Igor
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2009
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2636731/
https://ncbi.nlm.nih.gov/pubmed/19196983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0809444106
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados